Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial | Stroke and Vascular Neurology

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Current issue

Archive

For authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

See original article:

Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial - October 01, 2022

Correction

Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial

Online download statistics by month:

Online download statistics by month: February 2023 to March 2024

	Abstract	Full	Pdf
Feb 2023	71	73	23
Mar 2023	85	85	38
Apr 2023	76	77	16
May 2023	87	87	14
Jun 2023	84	84	7
Jul 2023	80	80	19
Aug 2023	172	172	29
Sep 2023	222	221	46
Oct 2023	244	244	31
Nov 2023	145	145	16
Dec 2023	84	84	11
Jan 2024	55	55	12
Feb 2024	71	71	10
Mar 2024	61	61	36
Total	1537	1539	308